Using a Machine Learning Approach to Identify Key Biomarkers for Renal Clear Cell Carcinoma

Abstract

Background The most common and deadly subtype of renal carcinoma is kidney renal clear cell carcinoma (KIRC), which accounts for approximately 75% of renal carcinoma. However, the main cause of death in KIRC patients is tumor metastasis. There are no obvious clinical features in the early stage of kidney cancer, and 25–30% of patients have already metastasized when they are first diagnosed. Moreover, KIRC patients whose local tumors have been removed by nephrectomy are still at high risk of metastasis and recurrence and are not sensitive to chemotherapy and radiotherapy, leading to poor prognosis. Therefore, early diagnosis and treatment of this disease are very important. Methods KIRC-related patient datasets were downloaded from the GEO database and TCGA database. DEG screening and GO, KEGG and GSEA enrichment analysis was firstly conducted and then the LASSO and support vector machine (SVM) RFE algorithms were adopted to identify KIRC-associated key genes in training sets and validate them in the test set. The clinical prognostic analysis including the association between the expression of key genes and the overall survival, stage, grade across KIRC, the immune infiltration difference between normal samples and cancer samples, the correlation between the key genes and immune cells, immunomodulator, immune subtypes of KIRC were investigated in this research. Results We finally screened out 4 key genes, including ACPP, ANGPTL4, SCNN1G, SLC22A7. The expression of key genes show difference among normal samples and tumor samples, SCNN1G and SLC22A7 could be predictor of prognosis of patients. The expression of key genes was related with the abundance of tumor infiltration immune cells and the gene expression of immune checkpoint. Conclusion This study screened the 4 key genes, which contributed to early diagnosis, prognosis assessment and immune target treatment of patients with KIRC.

Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes

“…Moreover, ANGPTL4 can participate in tumor energy metabolism in different NSCLC cells and affect cell proliferation through this process [ 82 ]. High expression of ANGPTL4 predicts adverse clinical outcomes in tumors, such as renal clear cell carcinoma, cholangiocarcinoma, melanoma, bladder cancer, and oral cancer [ 83 – 87 ]. In this study, ANGPTL4 was a high-risk gene that increased with tumor progression, suggesting a reduced survival rate and poor prognosis in LUAD patients.…”

GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer

“…It allowed us to extract features and rank their significance in distinguishing tumor and non-tumor groups. The top 30 genes obtained from SVM-RFE analysis were included in the subsequent analysis ( 51 ). The genes selected through these three machine learning techniques were successfully validated using the TCGA cohort.…”

Identification of molecular characteristics of FUT8 and alteration of core fucosylation in kidney renal clear cell cancer

“…However, almost 40% of these patients experience metastases following initial removal [ 8 , 9 ]. In addition, 25% of the KIRC patients are diagnosed with metastasis at the first visit due to no specific features at the early stage [ 10 , 11 ]. As for metastatic renal cell carcinoma, only few first-line drugs such as Sunitinib can be used, but drug resistance often occurs after 6-15 months of systematic treatment [ 12 ].…”